<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00600301</url>
  </required_header>
  <id_info>
    <org_study_id>APEC-OO13</org_study_id>
    <nct_id>NCT00600301</nct_id>
  </id_info>
  <brief_title>Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociación para Evitar la Ceguera en México</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asociación para Evitar la Ceguera en México</source>
  <brief_summary>
    <textblock>
      Diabetic macular edema is the most common cause of visual loss among patients with diabetic
      retinopathy. Pars plana vitrectomy has been reported to be effective for the treatment of
      diabetic macular edema. Previous report showed a limited improvement in visual acuity and
      macular thickness posterior intraoperative triamcinolone acetonide. Bevacizumab intravitreal
      injection has been proven be effective in the treatment of diabetic macular edema, in recent
      publications. The purpose of this study is to evaluate whether vitrectomy with and without
      intravitreal triamcinolone acetonide and bevacizumab injection affects vision outcome and
      macular thickness in patients with diabetic macular edema.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Diffuse Diabetic Macular Edema</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide and Bevacizumab</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diffuse diabetic macular edema

          -  Non proliferative diabetic retinopathy

          -  No VPP previa

          -  No previous treament with laser, Triamcinolone acetonide, and Bevacizumab

        Exclusion Criteria:

          -  Proliferative diabetic retinopathy

          -  Previous pars plana vitrectomy

          -  Previous treatment with diabetic macular edema

          -  Focal macular edema

          -  Macular Ischemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Maximiliano Gordon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APEC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maximiliano Gordon, MD</last_name>
    <phone>10841400</phone>
    <phone_ext>1171, 1172</phone_ext>
    <email>retinamex@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asociacion Para Evitar la Ceguera en Mexico</name>
      <address>
        <city>Mexico D.F.</city>
        <state>D.f.</state>
        <zip>04030</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maximiliano Gordon, MD</last_name>
      <phone>10841400</phone>
      <phone_ext>1171, 1172</phone_ext>
      <email>retinamex@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2006</study_first_submitted>
  <study_first_submitted_qc>January 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2008</study_first_posted>
  <last_update_submitted>January 23, 2008</last_update_submitted>
  <last_update_submitted_qc>January 23, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2008</last_update_posted>
  <keyword>Macula</keyword>
  <keyword>Edema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

